Stryker Acquiring Vexim and SpineJack VCF Implant

Stryker acquired Vexim, developer of the SpineJack® expandable vertebral compression fracture (VCF) implant, for ~US $191.0MM. The transaction is expected to close in 4Q17. For 2016, Vexim posted revenue of €18.5MM (~$22.0MM), +33% vs. 2015.

Vexim's portfolio complements Stryker's Interventional Spine division, which addresses vertebral...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us